Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

NCT00859898 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1093

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Dapagliflozin
DRUG: Metformin XR
DRUG: Metformin XR
DRUG: dapagliflozin matching Placebo
DRUG: metformin HCl Modified Release matching Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]